Carticaine: Clinical Trials

74 trials of Carticaine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

41 completed, 13 unknown, 7 not yet recruiting, 4 withdrawn. 29 Not applicable, 26 Phase 4, 6 Phase 2, 6 Phase 3, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable29Completed 15, Unknown 6, Not yet recruiting 4, Active not recruiting 2, Enrolling by invitation 1, Recruiting 1
Phase 426Completed 14, Unknown 4, Not yet recruiting 3, Terminated 2, Withdrawn 2, Suspended 1
Phase 26Completed 3, Withdrawn 2, Terminated 1
Phase 36Completed 5, Active not recruiting 1
Phase 14Completed 3, Unknown 1
Early Phase 13Completed 2, Unknown 1

Follow Carticaine: new trials by email Literature Review of Carticaine trials Research Report on Carticaine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Corneal Endothelium Health Following Articaine Ophthalmic Solution Administration
Articaine (CYKLX), Vehicle - Healthy Cornea
Phase 4Not yet recruitingLaboratoires Thea1652027-01-012026-09-24
Cost-Effectiveness of Upfront Supplemental Anaesthesia in Symptomatic Irreversible Pulpitis
Inferior Alveolar Nerve Block With 2% Lidocaine With 1:80,000 Adrenaline, Upfront Buccal Infiltration With 4% Articaine With 1:100,000 Adrenaline, Upfront Intraligamentary Injection With 2% Lidocaine With 1:80,000 Adrenaline - Irreversible Pulpitis, Anesthesia, Local
Phase 4Not yet recruitingJamia Millia Islamia2342026-10-302026-10-30
Anesthetic Effectiveness of Mental/Incisive Nerve Block Versus Inferior Nerve Block Using 4% Articaine and 2% Lidocaine in Mandibular First and Second Premolars With Symptomatic Irreversible Pulpitis.
Group A : MINB with 2% Lidocaine HCL+ 1:1000,000 Epinephrine - 1.8 ml, Group B : MINB with 4% Articaine HCL + 1:1000,000 Epinephrine - 1.8 ml, Group C : IANB with 2% Lidocaine HCL + 1:1000,000 Epinephrine - 1.8 ml - Pain
Not applicableNot yet recruitingFoundation University Islamabad1082026-10-012026-10-29
Different Local Anesthesia Techniques for Mandibular Primary Molar Pulpectomy
Computer-Controlled Local Anesthesia, Conventional Inferior Alveolar Nerve Block, Articaine hydrochloride with epinephrine 1:100,000 - Dental Anxiety, Pain
Not applicableNot yet recruitingRecep Tayyip Erdogan University Training and Research Hospital382026-08-122026-08-12
Pre-emptive Local Anesthesia and Sevoflurane Consumption in Pediatric Dental Anesthesia
Pre-emptive Local Anesthesia, Articaine With Epinephrine, Sevoflurane - Sevoflurane Consumption
Not applicableNot yet recruitingTC Erciyes University802026-08-012026-05-27
Pre-emptive Local Anesthesia and Emergence Behavior After Pediatric Dental General Anesthesia
Pre-emptive Local Anesthesia, Articaine Hydrochloride With Epinephrine - Emergence Delirium, Pediatric Dental General Anesthesia
Not applicableNot yet recruitingseher orbay yasli802026-06-012026-06-09
Articaine Versus Lidocaine for Supplemental Buccal Infiltration in Lower First Molars With Irreversible Pulpitis
Articaine 4% with epinephrine 1:100,000, Lidocaine 2% with Epinephrine 1:100,000 - Irreversible Pulpitis, Failed Inferior Alveolar Nerve Block
Phase 4CompletedRehman Medical Institute - RMI502026-03-032026-10-09
Anesthetic Effectiveness of Lidocaine Versus Articaine in Dentistry
lidocaine + epinephrine 1:100,000, Articaine 4% with epinephrine 1:100,000 - Dental Pain
Phase 4Not yet recruitingUniversidad Austral de Chile1002025-12-202025-11-17
COMT, MAOA, and SLC6A4 Polymorphisms and Inferior Alveolar Nerve Block Success
Inferior Alveolar Nerve Block with 4% Articaine - Symptomatic Irreversible Pulpitis (SIP)
Not applicableCompletedMarmara University952025-11-122026-07-14
Effects of Local Ketamine in Orthognathic Procedures
Ketamine, Articaine Hydrochloride + Epinephrine - Dentofacial Deformities, Analgesia
Not applicableActive not recruitingBezmialem Vakif University402025-06-212026-03-27
Pudendal Nerve Block With Articaine and Triamcinolone for Pudendal Neuralgia
Articaine and triamcinolone, Placebo (0.9% sodium chloride) - Pudendal Neuralgia Pudendal Nerve Entrapment Chronic Pelvic Pain
Not applicableActive not recruitingIrkutsk State Medical University1202025-01-152026-09-18
Assessment of Anesthetic Efficacy and Hemodynamic Stability of Two LA Drugs for Hypertensive Patients
4% Articaine HCL With 1:100,000 Epinephrine, 3% plain mepivacaine HCL - Hypertension
Not applicableEnrolling by invitationTanta University602025-01-102025-11-18
Comparison of Postoperative Effects of Articaine and Lidocaine in Mucogingival Surgery
Lidocaine hydrochloride 2% with epinephrine 1:100 000, Articaine 4% with epinephrine 1:100,000, Free gingival graft (FGG) - Local Analgesia Via Infiltration, Wound Heal
Not applicableCompletedPamukkale University432025-01-012025-08-28
Buccal Infiltration of Different Volumes of Articaine for Extraction.
1.8 ml of 4% Articaine, 3.6 ml of 4% Articaine - Buccal Infiltration, Articaine
Not applicableRecruitingQassim University1142024-11-242025-05-29
Pain and Microbial Reduction of Antimicrobial Corticosteroid Mixture Versus Cryotherapy in Necrotic Teeth
Local anaesthetic injection of 4% articaine with 1:100000 epinephrine, Tooth isolation, Access cavity preparation - Dental Pulp Necrosis
Not applicableCompletedCairo University282024-07-012025-06-05
Articaine Plus Dexmedetomidine in Supraclavicular Block
Articaine, Dexmedetomidine - Post Operative Pain, Acute
Not applicableUnknownBenha University662024-02-012024-05-23
Risk of Nerve Damage After Administration of Local Anesthesia
4% Articaine with 1:200,000 epinephrine, 2% lidocaine with 1:100,000 epinephrine - Inferior Alveolar Nerve Injuries
Phase 1UnknownCleveland Dental Institute802024-01-012024-08-26
Combination of Buffered Anesthetic to Treat Mandibular Molars
Sodium bicarbonate, Lidocaine w/ epi, Articaine w/ epi - Symptomatic Irreversible Pulpitis
Phase 4TerminatedIndiana University402023-12-052025-05-13
Different Volumes of Articaine for Inferior Alveolar Nerve Block in Irreversible Pulpitis
Articaine HCl 4 % / EPINEPHrine 1:100,000 in 1.8 mL Dental Cartridge - Drug Effect, Pulpitis - Irreversible
Phase 2CompletedArmed Forces Institute of Dentistry, Pakistan782023-12-012024-10-15
Anesthetic Efficacy of 1.8 ml Versus 3.6 ml of 4% Articaine Buccal Infiltration
3.6 ml 4% Articaine hydrochloride, 1.8 ml 4% Articaine hydrochloride - Symptomatic Irreversible Pulpitis
Not applicableUnknownCairo University702023-12-012023-11-07

Showing 20 of 74. Sign in to see all of them.

Conditions studied

Pain (11)  ·  Agnosia (4)  ·  Dental Caries (4)  ·  Pain, Postoperative (4)  ·  Dental Pulp Diseases (3)  ·  Periapical Periodontitis (3)  ·  Toothache (3)  ·  Pulpitis (2)  ·  Tooth, Impacted (2)  ·  Acute Kidney Injury (1)  ·  Aortic Valve Disease (1)  ·  Atrial myxoma, familial (1)  ·  Behavior, Addictive (1)  ·  Bicuspid Aortic Valve Disease (1)  ·  Child Behavior (1)

Sponsors

Cairo University (8)  ·  American Genomics, LLC (4)  ·  Netherlands Institute for Pigment Disorders (4)  ·  Virginia Commonwealth University (3)  ·  Ain Shams University (2)  ·  Helsinki University Central Hospital (2)  ·  Marmara University (2)  ·  Minia University (2)  ·  University of Michigan (2)  ·  28 Military Dental Centre Lahore (1)  ·  Ankara Yildirim Beyazıt University (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Armed Forces Institute of Dentistry, Pakistan (1)  ·  Benha University (1)  ·  Bezmialem Vakif University (1)

Countries

United States (12)  ·  Egypt (10)  ·  Turkey (Türkiye) (8)  ·  Brazil (4)  ·  Pakistan (4)  ·  Netherlands (3)  ·  Saudi Arabia (3)  ·  Finland (2)  ·  Chile (1)  ·  Colombia (1)  ·  Germany (1)  ·  Greece (1)  ·  India (1)  ·  Iran (1)  ·  Malaysia (1)

Top investigators

Albert Wolkerstorfer, MD, PhD (4)  ·  Martin Uram, MD (4)  ·  Menno A. De Rie, MD, PhD (3)  ·  Parthasarathy Madurantakam, DDS, PhD (3)  ·  Abeer Salem, MD (1)  ·  Ahmad Elheeny (1)  ·  Ahmed A Hashem, PhD (1)  ·  Albatool Baroom (1)  ·  Andre Chen, Msc (1)  ·  Asya A. Almansour, SBPD (1)  ·  Atyaf A. Alhunti (1)  ·  Aysan Lektemur Alpan, PhD DDS (1)  ·  Branislav V Bajkin, DMD, PhD (1)

Results publications

PMID 20006669, PMID 26868800, PMID 37192994, PMID 10028738, PMID 10832257, PMID 10916328, PMID 11733293, PMID 12366885, PMID 15051743, PMID 15793381, PMID 15966499, PMID 16320034, PMID 16554198, PMID 17082283, PMID 17138173, PMID 17670879, PMID 18155484, PMID 18436027, PMID 18762633, PMID 20831926, PMID 20921070, PMID 21772732, PMID 21881058, PMID 22915899, PMID 22924356, PMID 24455735, PMID 24702239, PMID 24862701, PMID 25885712, PMID 26202994, PMID 28186223, PMID 29043507, PMID 29257943, PMID 29397214, PMID 29573375, PMID 29742264, PMID 29980352, PMID 30734772, PMID 30883236, PMID 30887677, PMID 31028737, PMID 31365529, PMID 33029135, PMID 33384805, PMID 33487824, PMID 33990740, PMID 34195402, PMID 35162650, PMID 37313270, PMID 37865418

NIH funding

2009 (2)